Tests and procedures used to diagnose lung cancer include a combination of imaging tests and biopsy of an area of abnormal growth detected on a scan, or on clinical examination.
Initial imaging tests
Examples of these tests:
Small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) are staged differently.
Molecular / Biomarker testing (for NSCLC)
NSCLC may be further divided into different subtypes based on molecular testing of the lung biopsy specimen for certain genes or proteins. These results are used to determine the type of treatment recommendation.
Molecular testing is usually done on biopsy samples. However, in some situations when the biopsy speccimen is not available, the quantity is not enough for further tests, or where the biopsy cannot be performed, a blood test can be done to determine the molecular profile of the cancer. This is referred to as a "liquid biopsy".
Subscribe to our mailing list to get the updates to your email inbox...